Core Insights - The Tibet Autonomous Region is focusing on high-quality development of the pharmaceutical industry and drug safety by 2025, with ongoing revisions to the "95 National Standard for Tibetan Medicine" and submission of quality standard drafts for various products [1][2] Group 1: Industry Development - The Tibet Drug Administration has processed 9,511 approval items and issued over 2,700 electronic certificates, achieving a 100% completion rate for online administrative licensing [2] - There are currently 13 new drug varieties under research in the region, indicating a strong development momentum in Tibetan medicine [2] - The production value of Tibetan medical devices has reached over 10 million yuan, contributing to the innovation and development of Tibetan medicine [2] Group 2: Regulatory and Supportive Measures - The establishment of a one-on-one service guidance system aims to reduce risks and uncertainties for enterprises during market entry [2] - New policies have been introduced to support investment and promote high-quality development in the pharmaceutical industry, including the acceptance of incomplete application materials [2] - The approval of three Class 1 innovative drugs from Haikang Pharmaceutical Group marks a significant breakthrough for innovative drugs in Tibet [2] Group 3: Growth Metrics - Compared to 2020, Tibet has seen an increase of 35 new drug production enterprises and 18 wholesale enterprises, along with 44 new drug varieties and 50 approved numbers [3] - The production value of pharmaceuticals in 2024 is projected to increase by 3 billion yuan compared to 2020, with Tibetan medicine production valued at 3.4 billion yuan [3]

Core Points - The Tibet Autonomous Region has successfully entered 1,613 first-class prescription information into the "Chinese Tibetan Medicine Resource Database," laying a solid foundation for the protection of Tibetan medicine resources [1][2] - The Tibet Drug Administration is advancing high-quality development in the industry by revising the "95 Tibetan Medicine Standards" and has submitted quality standard revision drafts for 14 varieties to the National Medical Products Administration [1][2] - A total of 80 varieties have been submitted for approval, with 11 varieties already approved, and 44 varieties of standards research have been completed under the "Second Batch of Tibetan Medicine Standards Three-Year Action Plan" [1][2] - The region is actively promoting the development and utilization of Tibetan medicinal materials, having published the first batch of 9 processing varieties and guidelines [1][2] - The Tibet Drug Administration has also conducted the 2025 Tibetan Medicine Practitioner Qualification Examination, with 1,331 participants, receiving widespread recognition [1][2] - The development of the second phase of the smart drug supervision platform has been completed, enhancing the level of drug regulation and achieving seamless integration with national and regional public service systems [2] - The administration has developed technical standards for Tibetan medical devices, leading to the clinical use of five specialized medical devices, which have received positive feedback from Tibetan medical institutions and patients [2]